Lv51
1340 积分 2020-12-07 加入
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function
9天前
已完结
Repeat Radiofrequency Ablation Provides Survival Benefit in Patients With Intrahepatic Distant Recurrence of Hepatocellular Carcinoma
11天前
已完结
Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version)
13天前
已完结
Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort study
18天前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
21天前
已完结
Cure after surgery for hepato-pancreato-biliary cancers: A systematic review
27天前
已完结
Novel insights into molecular and immune subtypes of biliary tract cancers
28天前
已完结
Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers
1个月前
已关闭
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
1个月前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
1个月前
已完结
皖公网安备34019202002308
